4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer

Hyaluronan (HA) is a prominent component of the extracellular matrix at many sites of chronic inflammation, including type 1 diabetes (T1D), multiple sclerosis, and numerous malignancies. Recent publications have demonstrated that when HA synthesis is inhibited using 4-methylumbelliferone (4-MU), be...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagy, Nadine, Kuipers, Hedwich F., Frymoyer, Adam R., Ishak, Heather D., Bollyky, Jennifer B., Wight, Thomas N., Bollyky, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369655/
https://www.ncbi.nlm.nih.gov/pubmed/25852691
http://dx.doi.org/10.3389/fimmu.2015.00123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369655/
https://www.ncbi.nlm.nih.gov/pubmed/25852691
http://dx.doi.org/10.3389/fimmu.2015.00123

Ejemplares similares